Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

SMi ADMET 2014

30 Jun 2014 - 01 Jul 2014 - London, UK

Bookmark and Share

SMi presents the 9th annual conference on: ADMET

Enhancing drug quality by ADMET optimisation in discovery

SMi’s established ADMET conference has been a premier event in its field for almost a decade. The 9th annual event taking place on 30th June and 1st July in central London, will bring together even more industry leading experts to deliver over eighteen case study driven presentations. A focal point for anyone working in the market for drug discovery and development, attending provides a unique forum to engage with KOL’s and experts active in the field.

ADMET 2014 will enable delegates to gain valuable insights into enhancing drug quality by ADMET optimisation in discovery. It will focus on themes including Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes. Click here for the agenda  

 Previous events in the ADMET series have received positive feedback from the industry including, 

"Excellent" – Pharmidex, "Nice mix of attendees" – Grunenthal, "Good conference at general level to update your current knowledge" - Orion Corporation and "Great conference…well organised" - Sanofi

Key Speakers Include:

  • Natalie Gobeau, Metabolism and Pharmacokinetics, Novartis
  • Dietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-Aventis
  • Sarah Baldwin, In Vitro DMPK Manager, GSK
  • Chris Powell, VP Safety Assessment, GSK
  • Georg Schmitt, Head of Toxicology, Roche Pharmaceuticals
  • Richard Thompson, Principal Scientist, AstraZeneca
  • Franck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCB
  • Adina Tocoian, Senior Clinical Pharmacologist, UCB
  • David Fairman, Senior Clinical Pharmacokinetist, MedImmune

Reasons to Attend:

  • Understand how to integrate ADME and toxicity data to enhance the prediction and understanding of drug safety in humans 
  • Hear the latest updates on drug transporters including the evolving transporter strategies in drug development and the different roles of drug transporters in R&D 
  • Explore the ADME properties of peptides in drug discovery 
  • Evaluate and overcome the challenges of making an accurate human dose prediction 

Registration is now live. Click here to secure your place today and save £300.

For further details and to book your place, visit:

Alternatively contact the Team on +44 (0)20 7827 6000 or email 

Further information
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Substance Can Potentially Postpone Aging
Researchers bridge the gap between two main aging theories - repairs to the DNA and poor functioning mitochondria.
Untangling Cause Of Memory Loss In Neurodegenerative Diseases
NIH-funded mouse study identifies a possible therapeutic target for a family of disorders.
New Model for Understanding Human Myeloma
Researchers develop mouse model where mice carry six human genes involved in human tumour growth.
Preventing Alzheimer's in Mice
Researchers have prevented the Alzheimer’s development in mice by using a virus delivery system to transport a specific gene into the brain.
New Platform for Roundworms Could Speed Up Drug Delivery
Researchers have developed a large-scale in vitro drug discovery platform that could speed up scientific research.
"Junk" DNA Critical for Heart Function
Loss of noncoding elements of genome, known as enhancers, results in abnormalities of heart functions.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos